Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Leuk Lymphoma. 2017 Jul 18;59(4):821–828. doi: 10.1080/10428194.2017.1352089

Figure 3.

Figure 3

(a) Increased CD25 expression associates with inferior overall survival. (b) Increased CD25 expression risk stratifies patients with intermediate cytogenetics but not unfavorable cytogenetics. (c) Increased CD25 expression risk stratifies patients with intermediate cytogenetics but not unfavorable cytogenetics.